Home › Funds › EcoR1 Capital, LLC › NGNE
EcoR1 Capital, LLC position in NGNE
NEUROGENE INC COM · Health Care
EcoR1 Capital, LLC reported holding 1,271,342 shares of NGNE (NEUROGENE INC COM) in its Q2 2026 13F filing — a position valued at US$40.0M, representing 2.05% of its reported portfolio and ranking #9 among its reported holdings. EcoR1 Capital, LLC has disclosed NGNE holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How EcoR1 Capital, LLC's NGNE position evolved
EcoR1 Capital, LLC first disclosed a stake in NGNE in Q4 2023 at 1,271,342 shares (US$24.6M). The position peaked in Q1 2024 at 1,271,342 shares, worth US$64.7M. Across 11 filings, EcoR1 Capital, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,271,342 shares valued at US$40.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.27M | $24.64M | New |
| Q1 2024 | 1.27M | $64.71M | Hold |
| Q2 2024 | 1.27M | $46.26M | Hold |
| Q3 2024 | 1.27M | $53.35M | Hold |
| Q4 2024 | 1.27M | $29.06M | Hold |
| Q1 2025 | 1.27M | $14.89M | Hold |
| Q2 2025 | 1.27M | $19.01M | Hold |
| Q3 2025 | 1.27M | $22.03M | Hold |
| Q4 2025 | 1.27M | $26.19M | Hold |
| Q1 2026 | 1.27M | $25.63M | Hold |
| Q2 2026 | 1.27M | $39.98M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NGNE and 13F data
NGNE (NEUROGENE INC COM) is a Health Care company. 37 other funds we track also report a position in NGNE — the largest reported positions include Samsara BioCapital, LLC (US$54.0M), Casdin Capital (US$48.6M), Redmile Group, LLC (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NGNE
- Samsara BioCapital, LLC 1.72M sh · $54.00M · Q2 2026
- Casdin Capital 1.55M sh · $48.60M · Q2 2026
- Redmile Group, LLC 1.41M sh · $44.41M · Q2 2026
- RTW INVESTMENTS, LP 1.36M sh · $42.85M · Q2 2026
- BAKER BROS. ADVISORS LP 991.69K sh · $31.19M · Q2 2026
- Trails Edge Capital Partners, LP 714.88K sh · $22.48M · Q2 2026
- GREAT POINT PARTNERS LLC 352.18K sh · $11.08M · Q2 2026
- DAFNA Capital Management LLC 89.03K sh · $2.80M · Q2 2026
More on EcoR1 Capital, LLC
FAQ
How long has EcoR1 Capital, LLC held NGNE?
EcoR1 Capital, LLC has disclosed NGNE holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is EcoR1 Capital, LLC's current position in NGNE?
As of Q2 2026, EcoR1 Capital, LLC holds 1.27M shares of NGNE (NEUROGENE INC COM), valued at $39.98M, representing 2.05% of its reported portfolio and ranking #9.
Has EcoR1 Capital, LLC been buying or selling NGNE?
In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC held unchanged its position in NGNE. The position peaked in Q1 2024 at 1.27M shares.
Which other funds hold NGNE?
Other major institutional holders of NGNE include Samsara BioCapital, LLC, Casdin Capital, Redmile Group, LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.